You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Details for New Drug Application (NDA): 021165


✉ Email this page to a colleague

« Back to Dashboard


NDA 021165 describes CLARINEX, which is a drug marketed by Merck Sharp Dohme, Organon, and Organon Llc, and is included in five NDAs. It is available from one supplier. Additional details are available on the CLARINEX profile page.

The generic ingredient in CLARINEX is desloratadine; pseudoephedrine sulfate. There are sixteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the desloratadine; pseudoephedrine sulfate profile page.
Summary for 021165
Tradename:CLARINEX
Applicant:Organon
Ingredient:desloratadine
Patents:0
Pharmacology for NDA: 021165
Suppliers and Packaging for NDA: 021165
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLARINEX desloratadine TABLET;ORAL 021165 NDA Organon LLC 78206-119 78206-119-01 100 TABLET, FILM COATED in 1 BOTTLE (78206-119-01)
CLARINEX desloratadine TABLET;ORAL 021165 NDA Organon LLC 78206-188 78206-188-01 100 TABLET, FILM COATED in 1 BOTTLE (78206-188-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Dec 21, 2001TE:ABRLD:Yes

Expired US Patents for NDA 021165

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon CLARINEX desloratadine TABLET;ORAL 021165-001 Dec 21, 2001 ⤷  Try a Trial ⤷  Try a Trial
Organon CLARINEX desloratadine TABLET;ORAL 021165-001 Dec 21, 2001 ⤷  Try a Trial ⤷  Try a Trial
Organon CLARINEX desloratadine TABLET;ORAL 021165-001 Dec 21, 2001 ⤷  Try a Trial ⤷  Try a Trial
Organon CLARINEX desloratadine TABLET;ORAL 021165-001 Dec 21, 2001 ⤷  Try a Trial ⤷  Try a Trial
Organon CLARINEX desloratadine TABLET;ORAL 021165-001 Dec 21, 2001 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.